Next Generation ICD and CRT-D Solutions

Powerfully Connected

Abbott's ICD and CRT-D solutions offer built-in smartphone connectivity — to help transform how you and patients connect.

The secure myMerlinPulse™ app streamlines remote monitoring to encourage continuous, reliable patient engagement so that you may have earlier detection of clinically relevant events.


Pioneering  Dynamic Technology

Abbott’s next generation ICD and CRT-D solutions combine smartphone-enabled remote monitoring with patient-focused enhancements to help you deliver accurate, optimized care.

    in a small, contoured shape with 1.5T and 3T MRI compatibility
    of challenging ventricular arrhythmias with Abbott's unique discriminator — VF Therapy Assurance¹
    with faster, more intuitive programming options
Gallant DR and HF devices

Patient-Centric  Outcomes

Abbott’s ICD and CRT-D solutions are designed to seamlessly integrate into your patients' day-to-day lives, making it possible for you to achieve clinically meaningful outcomes.

98.4% of patients

did not receive inappropriate shocks at 1 year (CI: 97.2-99.2, p<0.0001).²

22% fewer hospitalizations

for patients with SyncAV™ CRT technology enabled versus patients with the technology disabled.³

Next Generation ICD and CRT-D Solutions

Resource Library

Customer Brochure - Gallant and Entrant Devices Overview

Learn about Abbott’s next generation ICD and CRT-D solutions with built-in smartphone connectivity and patient-focused enhancements that help to ensure accurate, optimized care.

Gallant Customer Brochure

Remote Monitoring Clinician Guide

Get guidance and recommendations for how to onboard patients using myMerlinPulse™ app for remote monitoring.

Remote Monitoring Clinican Guide

Smartphone Connectivity Guide

Learn how built-in smartphone connectivity helps to streamline remote monitoring and encourage continuous, reliable patient engagement.

Smartphone Connectivity Guide

Empowering You. Empowering Your Patients. Powered By Abbott.


  1. Data on file. 60101422 Internal Validation Report. Total 2019 global high-voltage implants, all manufacturers, estimated to be 440,434 units (Source: Abbott Market Research).
  2. Veltmann C, Wöhrle, Busch M, et al. Reduction of inappropriate shocks of ICDs with enhanced SVT discriminators. EUROPACE presentation; 2017.
  3. Varma N, O’Donnell D, Bassiouny M, et al. Programming cardiac resynchronization therapy for electrical synchrony: reaching beyond left bundle branch block and left ventricular activation delay. J Am Heart Assoc. 2018;7:e007489.


Brief Summary: This product is intended for use by or under the direction of a Physician. Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

MAT-2009257 v1.0